SGMO Fail-to-Deliver

Sangamo Therapeutics, Inc. (SGMO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $30.7M, listed on PNK, employing roughly 127 people, carrying a beta of 1.29 to the broader market. Sangamo Therapeutics, Inc. Led by Alexander D. Macrae Ch.B, public since 2000-04-06.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date

2026-06-24

Latest FTD Quantity

25.2K

Latest Price

$0.07

30-Day Avg FTD

325.5K

30-Day Total FTD

9.8M

Showing 30 days of SEC fail-to-deliver data for Sangamo Therapeutics, Inc..

Learn how fails-to-deliver is reported and how to read the data →